Abstract | BACKGROUND: Both activated tumor-infiltrating lymphocytes (TILs) and immune-suppressive cells, such as regulatory T cells (Tregs), in the tumor microenvironment (TME) play an important role in the prognosis of patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: The densities of TILs, programmed death receptor 1 (PD-1) + T cells, and forkhead box P3 (Foxp3) + T cells were analyzed by immunohistochemical staining. The associations of the immunological status of the PDAC microenvironment with overall survival (OS) time and disease-free survival (DFS) time were evaluated. RESULTS: PDAC patients with a high density of TILs in the TME or PD-1-positive T cells in tertiary lymphoid aggregates (TLAs) demonstrated a significantly better prognosis than those with a low density of TILs or PD-1-negativity, respectively. Moreover, PDAC patients with high levels of Foxp3-expressing T cells showed a worse prognosis than those with low levels of Foxp3-expressing T cells. Importantly, even with a high density of the TILs in TME or PD-1-positive T cells in TLAs, PDAC patients with high levels of Foxp3-expressing T cells showed a worse prognosis than patients with low levels of Foxp3-expressing T cells. A PDAC TME with a high density of TILs/high PD-1 positivity/low Foxp3 expression was an independent predictive marker associated with superior prognosis. CONCLUSION: Combined assessment of TILs, PD-1+ cells, and Foxp3+ T cells in the TME may predict the prognosis of PDAC patients following surgical resection.
|
Authors | Sachie Kiryu, Zensho Ito, Machi Suka, Tsuuse Bito, Shin Kan, Kan Uchiyama, Masayuki Saruta, Taigo Hata, Yuki Takano, Shuichi Fujioka, Takeyuki Misawa, Takashi Yamauchi, Hiroyuki Yanagisawa, Nobuhiro Sato, Toshifumi Ohkusa, Haruo Sugiyama, Shigeo Koido |
Journal | BMC cancer
(BMC Cancer)
Vol. 21
Issue 1
Pg. 1197
(Nov 10 2021)
ISSN: 1471-2407 [Electronic] England |
PMID | 34758773
(Publication Type: Journal Article)
|
Copyright | © 2021. The Author(s). |
Chemical References |
- FOXP3 protein, human
- Forkhead Transcription Factors
- PDCD1 protein, human
- Programmed Cell Death 1 Receptor
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Pancreatic Ductal
(immunology, mortality, pathology, surgery)
- Disease-Free Survival
- Female
- Follow-Up Studies
- Forkhead Transcription Factors
(metabolism)
- Humans
- Lymphocytes, Tumor-Infiltrating
(immunology, metabolism)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(epidemiology, prevention & control)
- Pancreas
(immunology, pathology, surgery)
- Pancreatectomy
- Pancreatic Neoplasms
(immunology, mortality, pathology, surgery)
- Prognosis
- Programmed Cell Death 1 Receptor
(metabolism)
- Retrospective Studies
- Tumor Microenvironment
(immunology)
|